home / stock / rxdx / rxdx quote
Last: | $199.92 |
---|---|
Change Percent: | 0.12% |
Open: | $199.68 |
Close: | $199.92 |
High: | $199.98 |
Low: | $199.6 |
Volume: | 1,860,653 |
Last Trade Date Time: | 06/15/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$199.92 | $199.68 | $199.92 | $199.98 | $199.6 | 1,860,653 | 06-15-2023 |
$199.74 | $199.02 | $199.74 | $199.74 | $199.02 | 933,769 | 06-14-2023 |
$198.99 | $198.99 | $198.99 | $199.02 | $198.92 | 3,518,039 | 06-13-2023 |
$198.92 | $198.99 | $198.92 | $199 | $198.92 | 1,349,197 | 06-12-2023 |
$198.99 | $199 | $198.99 | $199.1 | $198.91 | 1,002,667 | 06-09-2023 |
$198.98 | $199.2 | $198.98 | $199.2 | $198.85 | 299,545 | 06-08-2023 |
$198.84 | $199.08 | $198.84 | $199.08 | $198.77 | 480,069 | 06-07-2023 |
$198.85 | $198.8 | $198.85 | $199.08 | $198.73 | 402,416 | 06-06-2023 |
$198.8 | $198.75 | $198.8 | $198.85 | $198.71 | 341,169 | 06-05-2023 |
$198.83 | $198.75 | $198.83 | $198.87 | $198.6 | 366,143 | 06-02-2023 |
$198.65 | $198.6 | $198.65 | $198.77 | $198.56 | 535,785 | 06-01-2023 |
$198.7 | $198.5 | $198.7 | $198.79 | $198.38 | 1,032,356 | 05-31-2023 |
$198.58 | $198.62 | $198.58 | $198.64 | $198.37 | 1,210,003 | 05-30-2023 |
$198.6 | $198.61 | $198.6 | $198.79 | $198.51 | 1,086,705 | 05-29-2023 |
$198.6 | $198.61 | $198.6 | $198.79 | $198.51 | 1,086,705 | 05-26-2023 |
$198.6 | $198.7 | $198.6 | $198.745 | $198.56 | 2,172,849 | 05-25-2023 |
$198.67 | $198.67 | $198.67 | $198.8 | $198.6 | 1,687,270 | 05-24-2023 |
$198.7 | $198.8 | $198.7 | $198.99 | $198.68 | 2,687,198 | 05-23-2023 |
$193.45 | $192.5 | $193.45 | $193.58 | $192.42 | 895,224 | 05-22-2023 |
$192.5 | $193.25 | $192.5 | $193.3 | $192.16 | 921,158 | 05-19-2023 |
News, Short Squeeze, Breakout and More Instantly...
Prometheus Biosciences Inc. Company Name:
RXDX Stock Symbol:
NASDAQ Market:
NEW YORK, NY / ACCESSWIRE / May 25, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Prometheus Biosciences, Inc. (NASDAQ:RXDX...
SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutics for the treatment of immune-mediated disease...